1. Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response
   Jia Yan et al, 2023, BMC Complementary Medicine and Therapies CrossRef
2. Cell metabolomics study on synergistic anti‐hepatocellular carcinoma effect of Aidi injection combined with doxorubicin
   Yanli Wang et al, 2022, Biomedical Chromatography CrossRef
3. Breaking Glucose Transporter 1/Pyruvate Kinase M2 Glycolytic Loop Is Required for Cantharidin Inhibition of Metastasis in Highly Metastatic Breast Cancer
   Yanhong Pan et al, 2019, Frontiers in Pharmacology CrossRef
4. Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention
   Dian Jin et al, 2023, Frontiers in Pharmacology CrossRef
5. Bibliometric Analysis and Systemic Review of Cantharidin Research Worldwide
   Tianmu He et al, 2024, Current Pharmaceutical Biotechnology CrossRef
6. Role of the PP2A Pathway in Cholangiocarcinoma: State of the Art and Future Perspectives
   Ion Cristóbal et al, 2022, Cancers CrossRef